Q3 FY2026 · ended Sep 30, 2026 · Revenue $3.58B, +4.6% YoY · Filed Oct 29, 2026
Davita Inc. (DVA) files with the SEC under industry code 8090, Services-Misc Health & Allied Services, NEC. In Q3 of fiscal 2026, the quarter ended Sep 30, 2026, it reported revenue of $3.6 billion and net income of $222.9 million. Free cash flow was $359.3 million. As of Sep 30, 2026 it held $604.7 million in cash and investments and $13.3 billion in total debt.
Revenue
$3.58B
+4.6% vs year-ago quarter
Net income
$222.93M
+48.3% vs year-ago quarter
Operating cash flow
$518.83M
-38.3% vs year-ago quarter
Free cash flow
$359.34M
-46.8% vs year-ago quarter
EPS
$3.40
+66.7% vs year-ago quarter
Dividend per share
None
Shares outstanding
62.90M
-10.9% vs year-ago quarter
Net cash
$-12.68B
Q3 FY2026
Operating margin
15.0%
TTM
Company profile
- Industry
- Services-Misc Health & Allied Services, NEC (SIC 8090)
- Listed as
- DVA (NYSE)
- Fiscal year ends
- December 31
- Incorporated in
- DE
- Headquarters
- Denver, CO
- SEC filer status
- Large accelerated filer
- SEC CIK
- 927066
- Former names
- DAVITA HEALTHCARE PARTNERS INC. (until Aug 12, 2016); DAVITA INC (until Nov 2, 2012); TOTAL RENAL CARE HOLDINGS INC (until Jan 28, 2000)
Other Services-Misc Health & Allied Services, NEC companies
- Fresenius Medical Care AG FMS
- Sotera Health Co SHC
- Progyny, Inc. PGNY
- agilon health, inc. AGL
- Charming Medical Ltd MCTA
- Viemed Healthcare, Inc. VMD
- Park Dental Partners, Inc. PARK
- Marpai, Inc. MRAI
All 15 Services-Misc Health & Allied Services, NEC companies
Key figures
Fiscal-year totals from the annual reports; switch to Annual for the full-year view. Balance sheet lines are as of each year end.
| Line | Q3 FY2026 Sep 30, 2026 |
Q2 FY2026 Jun 30, 2026 |
Q1 FY2026 Mar 31, 2026 |
Q4 FY2025 Dec 31, 2025 |
Q3 FY2025 Sep 30, 2025 |
|---|---|---|---|---|---|
| Revenue | $3.6B | $3.6B | $3.4B | $3.6B | $3.4B |
| Operating income | $499.3M | $579.0M | $481.9M | $561.1M | $505.8M |
| Net income | $222.9M | $265.4M | $197.5M | $234.2M | $150.3M |
| Diluted EPS | $3.40 | $4.02 | $2.87 | $3.29 | $2.04 |
| Operating cash flow | $518.8M | $490.1M | $320.8M | $540.7M | $841.5M |
| Free cash flow | $359.3M | $320.3M | $218.8M | $395.3M | $675.4M |
| Total assets | $17.8B | $17.7B | $17.5B | $17.5B | $17.6B |
| Total liabilities | $16.7B | $16.6B | $16.5B | $16.3B | $16.2B |
| Stockholders' equity | -$591.1M | -$765.1M | -$755.5M | -$651.1M | -$571.9M |
| Cash and investments | $604.7M | $727.2M | $706.0M | $741.7M | $776.6M |
| Total debt | $13.3B | $13.3B | $13.1B | $12.8B | $12.7B |
Recent SEC filings
| Form | Description | Filed | Period |
|---|---|---|---|
| 10-Q | Quarterly report | Oct 29, 2026 | Sep 30, 2026 |
| 8-K |
Current report
Results of operations
|
Oct 29, 2026 | Oct 29, 2026 |
| 10-Q | Quarterly report | Aug 4, 2026 | Jun 30, 2026 |
| 8-K |
Current report
Results of operations
|
Aug 4, 2026 | Aug 4, 2026 |
| 8-K |
Current report
Material agreement, New debt, Shareholder vote results
|
Jun 8, 2026 | Jun 4, 2026 |
| 10-Q | Quarterly report | May 5, 2026 | Mar 31, 2026 |
All 1001 Davita Inc. SEC filings
Source: SEC EDGAR filings. This is company-reported data, not investment advice.